Clinical Trial

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

Name: Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy — clinical trial record (NCT07453095)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase 2, multicentre, single arm study that evaluates the efficacy and safety of glofitamab in MCL patients with inadequate response or relapse following CAR T-cell therapy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-26

Trial Details

NCT Number	NCT07453095
Lead Sponsor	Fondazione Italiana Linfomi - ETS
Conditions	Mantle Cell Lymphoma
Enrollment	41 participants
Start Date	2026-06-05
Primary Completion	2028-07-15 (estimated)
Study Completion	2030-06-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-25